Announcement
·
06 May 2025
·
M42 appoints Dimitris Moulavasilis as Group CEO

Revolutionizing Disease Treatment: From Discovery to Delivery

25 April 2025
Healthcare Innovations and Visionaries
Abu Dhabi Global Healthcare Week 2025

About the Speakers

  • Islam Eltantawy
    General Director for IROS
  • Jared Bearss
    COO, Halia Therapeutics
  • Paul Jones
    Chief Executive Officer, Omics Centre of Excellence

    Paul Jones, CEO of M42’s Omics Centre of Excellence, drives advancements in genomics and precision medicine with 30+ years of experience in global genomic programs and personalized health solutions.

    Watch Next